Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy: Report of two cases

Yoshikane Yamauchi, Yotaro Izumi, Hideki Yashiro, Masanori Inoue, Seishi Nakatsuka, Masafumi Kawamura, Hiroaki Nomori

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Lung cancers in the residual lungs of patients who have undergone pneumonectomies are often unresectable, primarily because of the risks of overt pulmonary function losses. Percutaneous cryoablation of lung tumors is a potentially minimally invasive technique that has recently been used in the treatment of lung cancers and metastatic lung tumors. Here, we present two patients who had previously undergone pneumonectomies, in whom lung cancers in the residual lungs were treated by cryoablation. In both patients, the procedures were performed safely without any complications, such as airway bleeding, hemothoraces, or pneumothoraces. The changes in pulmonary functions after the procedures were minimal: % vital capacity (2 1% and 2 4%), and %FEV 1( - 1% and + 10%) in the first and second patients, respectively. The performance statuses were maintained at zero in both patients after cryoablation. In the first patient, local control has been maintained for 4 years. In the second patient, local control was maintained for 2 years until the patient died of distant metas tases. This is, to our knowledge, the first reported case of lung cryoablation in residual lungs of patients who have previously undergone pneumonectomiespneumonectomies. Application of percutaneous cryoablation may represent a new treatment option for lung tumors in patients who have previously undergone pneumonectomies.

Original languageEnglish
Pages (from-to)1633-1637
Number of pages5
JournalChest
Volume140
Issue number6
DOIs
Publication statusPublished - 2011 Dec

Fingerprint

Cryosurgery
Pneumonectomy
Lung
Lung Neoplasms
Hemothorax
Neoplasms
Vital Capacity
Pneumothorax
Hemorrhage

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy : Report of two cases. / Yamauchi, Yoshikane; Izumi, Yotaro; Yashiro, Hideki; Inoue, Masanori; Nakatsuka, Seishi; Kawamura, Masafumi; Nomori, Hiroaki.

In: Chest, Vol. 140, No. 6, 12.2011, p. 1633-1637.

Research output: Contribution to journalArticle

Yamauchi, Yoshikane ; Izumi, Yotaro ; Yashiro, Hideki ; Inoue, Masanori ; Nakatsuka, Seishi ; Kawamura, Masafumi ; Nomori, Hiroaki. / Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy : Report of two cases. In: Chest. 2011 ; Vol. 140, No. 6. pp. 1633-1637.
@article{91a54e36c5f9482b8c61fdd6b3dcd9f1,
title = "Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy: Report of two cases",
abstract = "Lung cancers in the residual lungs of patients who have undergone pneumonectomies are often unresectable, primarily because of the risks of overt pulmonary function losses. Percutaneous cryoablation of lung tumors is a potentially minimally invasive technique that has recently been used in the treatment of lung cancers and metastatic lung tumors. Here, we present two patients who had previously undergone pneumonectomies, in whom lung cancers in the residual lungs were treated by cryoablation. In both patients, the procedures were performed safely without any complications, such as airway bleeding, hemothoraces, or pneumothoraces. The changes in pulmonary functions after the procedures were minimal: {\%} vital capacity (2 1{\%} and 2 4{\%}), and {\%}FEV 1( - 1{\%} and + 10{\%}) in the first and second patients, respectively. The performance statuses were maintained at zero in both patients after cryoablation. In the first patient, local control has been maintained for 4 years. In the second patient, local control was maintained for 2 years until the patient died of distant metas tases. This is, to our knowledge, the first reported case of lung cryoablation in residual lungs of patients who have previously undergone pneumonectomiespneumonectomies. Application of percutaneous cryoablation may represent a new treatment option for lung tumors in patients who have previously undergone pneumonectomies.",
author = "Yoshikane Yamauchi and Yotaro Izumi and Hideki Yashiro and Masanori Inoue and Seishi Nakatsuka and Masafumi Kawamura and Hiroaki Nomori",
year = "2011",
month = "12",
doi = "10.1378/chest.11-0459",
language = "English",
volume = "140",
pages = "1633--1637",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy

T2 - Report of two cases

AU - Yamauchi, Yoshikane

AU - Izumi, Yotaro

AU - Yashiro, Hideki

AU - Inoue, Masanori

AU - Nakatsuka, Seishi

AU - Kawamura, Masafumi

AU - Nomori, Hiroaki

PY - 2011/12

Y1 - 2011/12

N2 - Lung cancers in the residual lungs of patients who have undergone pneumonectomies are often unresectable, primarily because of the risks of overt pulmonary function losses. Percutaneous cryoablation of lung tumors is a potentially minimally invasive technique that has recently been used in the treatment of lung cancers and metastatic lung tumors. Here, we present two patients who had previously undergone pneumonectomies, in whom lung cancers in the residual lungs were treated by cryoablation. In both patients, the procedures were performed safely without any complications, such as airway bleeding, hemothoraces, or pneumothoraces. The changes in pulmonary functions after the procedures were minimal: % vital capacity (2 1% and 2 4%), and %FEV 1( - 1% and + 10%) in the first and second patients, respectively. The performance statuses were maintained at zero in both patients after cryoablation. In the first patient, local control has been maintained for 4 years. In the second patient, local control was maintained for 2 years until the patient died of distant metas tases. This is, to our knowledge, the first reported case of lung cryoablation in residual lungs of patients who have previously undergone pneumonectomiespneumonectomies. Application of percutaneous cryoablation may represent a new treatment option for lung tumors in patients who have previously undergone pneumonectomies.

AB - Lung cancers in the residual lungs of patients who have undergone pneumonectomies are often unresectable, primarily because of the risks of overt pulmonary function losses. Percutaneous cryoablation of lung tumors is a potentially minimally invasive technique that has recently been used in the treatment of lung cancers and metastatic lung tumors. Here, we present two patients who had previously undergone pneumonectomies, in whom lung cancers in the residual lungs were treated by cryoablation. In both patients, the procedures were performed safely without any complications, such as airway bleeding, hemothoraces, or pneumothoraces. The changes in pulmonary functions after the procedures were minimal: % vital capacity (2 1% and 2 4%), and %FEV 1( - 1% and + 10%) in the first and second patients, respectively. The performance statuses were maintained at zero in both patients after cryoablation. In the first patient, local control has been maintained for 4 years. In the second patient, local control was maintained for 2 years until the patient died of distant metas tases. This is, to our knowledge, the first reported case of lung cryoablation in residual lungs of patients who have previously undergone pneumonectomiespneumonectomies. Application of percutaneous cryoablation may represent a new treatment option for lung tumors in patients who have previously undergone pneumonectomies.

UR - http://www.scopus.com/inward/record.url?scp=83455213916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455213916&partnerID=8YFLogxK

U2 - 10.1378/chest.11-0459

DO - 10.1378/chest.11-0459

M3 - Article

C2 - 22147822

AN - SCOPUS:83455213916

VL - 140

SP - 1633

EP - 1637

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -